Susan R. Kahn
Susan R. Kahn publishes mostly in Internal Medicine, Surgery and Cardiology and Cardiovascular Medicine, on topics such as Venous Thromboembolism Diagnosis and Management, Diagnosis and Treatment of Venous Diseases and Atrial Fibrillation Management and Outcomes.
- World rank
- #55,529 of 7,710,434 ranked researchers
- Rank in Canada
- #1,575 of 183,316
- Works
- 477
- Citations
- 43k
- Citations per work
- 90.5
What does Susan R. Kahn research?
Susan R. Kahn's work is mostly in Medicine (70%), Health Professions (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences35273.7%
- Medicine33269.7%
- Health Professions194.0%
- Everything else12526.3%
- 1Internal Medicine29% of their works
- 2Surgery16% of their works
- 3Cardiology and Cardiovascular Medicine14% of their works
- 4Hematology8% of their works
- 5Emergency Medical Services4% of their works
- 6Pulmonary and Respiratory Medicine3% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Diagnosis and Treatment of Venous Diseases
- Atrial Fibrillation Management and Outcomes
- Blood Coagulation and Thrombosis Mechanisms
- Central Venous Catheters and Hemodialysis
- Heparin-Induced Thrombocytopenia and Thrombosis
- Acute Ischemic Stroke Management
- Peripheral Artery Disease Management
Which keywords describe Susan R. Kahn's research?
The keywords of their largest research topics: Clinical Practice Guidelines, Antithrombotic Therapy, Risk Factors, Diagnosis, Pulmonary Embolism, Venous Thromboembolism, Guidelines and Chronic Venous Insufficiency.
- Thrombolysis
- Ischemic Stroke
- Thrombosis
- Revascularization
- Catheter-Related Infections
- Protease-Activated Receptors
- Anticoagulant Therapy
- Chronic Venous Insufficiency
- Venous Thromboembolism
- Diagnosis
- Antithrombotic Therapy
- Clinical Practice Guidelines
- Risk Factors
- Pulmonary Embolism
- Guidelines
- Varicose Veins
- Atrial Fibrillation
- Thrombin
- Central Venous Catheterization
- Heparin-Induced Thrombocytopenia
- Angioplasty
- Peripheral Arterial Disease
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Clinical Practice Guidelines5072 topics
- Antithrombotic Therapy4722 topics
- Risk Factors4163 topics
- Diagnosis4002 topics
- Pulmonary Embolism3761 topic
- Venous Thromboembolism3761 topic
- Guidelines1382 topics
- Chronic Venous Insufficiency1311 topic
- Varicose Veins1311 topic
- Anticoagulant Therapy1181 topic
- Atrial Fibrillation1181 topic
- Protease-Activated Receptors961 topic
- Thrombin961 topic
- Catheter-Related Infections521 topic
- Central Venous Catheterization521 topic
- Revascularization402 topics
- Heparin-Induced Thrombocytopenia241 topic
- Thrombosis241 topic
- Angioplasty201 topic
- Ischemic Stroke201 topic
- Peripheral Arterial Disease201 topic
- Thrombolysis201 topic
Where does Susan R. Kahn work?
Susan R. Kahn's main affiliation in the publication record is Jewish General Hospital, Canada.
How many publications and citations does Susan R. Kahn have?
OpenAlex counts 477 works and 43,181 citations for Susan R. Kahn, an h-index of 92, ranking #55,529 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Susan R. Kahn. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.